In gliomas, CTX inhibits the expression of MMP-2 and to achieve maximal inhibition, a dual system that employs an anti-cancer drug entrapped in or conjugated to a nano-carrier, together with the conjugation of CTX is used. Here, MMP2 is linked to central nervous system cancer.